Skip to main content

Elanco Animal Health Inc

For the period ended Sep 30, 2026. Filed Nov 6, 2026.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Sep 30, 2026 · Filed Nov 6, 2026

ELAN$26.76-0.3%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

CONDENSED CONSOLIDATED BALANCE SHEETS

(in millions, except share data)

September 30, 2026December 31, 2025
(Unaudited)
Assets
Current Assets
Cash and cash equivalents$465$545
Accounts receivable, net992873
Other receivables7167
Inventories1,8181,737
Prepaid expenses and other380236
Total current assets3,7263,458
Noncurrent Assets
Property and equipment, net1,4381,409
Goodwill4,7974,779
Other intangibles, net3,0323,408
Other noncurrent assets347304
Total assets$13,340$13,358
Liabilities and Equity
Current Liabilities
Accounts payable$416$368
Sales rebates and discounts443416
Current portion of long-term debt and finance lease liability7474
Other current liabilities854739
Total current liabilities1,7871,597
Noncurrent Liabilities
Long-term debt and finance lease liability3,6333,943
Liability for sale of future revenue309304
Deferred taxes424382
Other noncurrent liabilities559585
Total liabilities6,7126,811
Commitments and Contingencies
Equity
Preferred stock, 1,000,000,000 shares authorized, no par value; none issued——
Common stock, no par value, 5,000,000,000 shares authorized, 499,726,948 and 496,975,154 shares issued and outstanding as of September 30, 2026 and December 31, 2025, respectively——
Additional paid-in capital8,8988,870
Accumulated deficit(2,053)(2,182)
Accumulated other comprehensive loss(217)(141)
Total equity6,6286,547
Total liabilities and equity$13,340$13,358

2026 Q3 Form 10-Q | 6

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.